An executive in the insurance industry, George Argyros, Jr., is the founder and president of Elite Financial Group, a holding company that provides turnkey life insurance premium finance programs. Outside of this role, George Argyros, Jr., has donated funds to numerous organizations, including the Muscular Dystrophy Association (MDA), which has announced new research and development grants.
The MDA will distribute 29 new research and development grants as part of its Winter 2017 grant cycle. The latest grants are part of the organization’s commitment to double its spending on drug development and trials by 2020.
The new awards total more than $7 million and will help researchers study key questions related to muscular dystrophy. Award recipients include Mattia Quattrocelli, from Northwestern University’s Center for Genetic Medicine. She will study how glucocorticoids affect muscle repair and regeneration in individuals with Duchenne muscular dystrophy (DMD). Another recipient is James Novak, a postdoctoral associate at Children’s Research Institute who will study why exon-skipping drugs can effectively reach muscles undergoing repair.
To learn more about the MDA Winter 2017 grant cycle, visit Strongly.MDA.org/Keeping-Up-The-Momentum.